Granules India Limited

15.5%

inancial Highlights Income from Operations Gross margin and margin % EBITDA and EBITDA margins 15.5% 8,498 7,356 4,700 4,600 4,500 4,400 4,300 4,200 4,100 4,000 3,900 3,800 3,700 3,600

59.5%

4,300 4,200 4,100 4,000 3,900 3,800 3,700 3,600 3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY2

64.0%

4,000 3,900 3,800 3,700 3,600 3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,0

62.0%

3,900 3,800 3,700 3,600 3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,9

60.0%

3,800 3,700 3,600 3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,8

58.0%

3,700 3,600 3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,7

56.0%

3,600 3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,700 1,6

54.0%

3,500 3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,700 1,600 1,5

52.0%

3,400 3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,700 1,600 1,500 1,4

50.0%

3,300 3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,700 1,600 1,500 1,400 1,3

54.2%

3,200 3,100 3,000 59.5% 4,380 59.5% 64.0% 62.0% 60.0% 58.0% 56.0% 54.0% 52.0% 50.0% 54.2% 54.2% 4,608 Q1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,700 1,600 1,500 1,400 1,300 1,2

25.0%

1FY21 Q1FY22 2,100 2,000 1,900 1,800 1,700 1,600 1,500 1,400 1,300 1,200 1,100 1,000 25.0% 23.7% 1,836 2,014 Q1FY21 Q1FY22 Q1FY21 Q1FY22 Gross margin Gross margin% EBITDA Value

As Encl

1

Total GPI products include

1

As Encl

Granules India Limited Q1FY22 Earnings Presentation 1 Safe Harbor The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any investor should subscribe / purchase the company shares. The Company makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information contained herein. This presentation may include certain “forward looking statements”. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from these statements. Important factors that could cause actual results to differ materially from

Total GPI products include

CII – 7 PFOS – 4 Liquid Orals - 3 IMS value for these products is approximately $ 8,518 mn Source IMS MAT May 2021 8 Improving returns; meeting increased working capital requirement: 5-year trajectory focus on OCF generation for funding capex while Net Debt & Net debt-to-EBITDA (x) Cash-to-Cash cycle (days) Free Cash Flow (FCF) (In ₹ Mn) 8,704 3.1x 9,082 2.4x 6,138 2.1x 6,058 5,752 1.2x 0.7x 135 125 114 109 117 2,919 1,615 -1,284 -172 -4,471 Mar'17 Mar'18 Mar'19 Mar'20 Mar'21 Mar'17 Mar'18 Mar'19 Mar'20 Mar'21 Mar'17 Mar'18 Mar'19 Mar'20 Mar'21 ROCE (%) ROE (%) Operating Cash Flow (OCF) 4,762 4,325 30.7% 27.4% 23.7% 14.7% 17.0% 20.5% 21.0% 19.9% 16.7% 12.0% 2,622 1,882 Mar'17 Mar'18 Mar'19 Mar'20 Mar'21 Mar'17 Mar'18 Mar'19 Mar'20 Mar'21 Mar'17 Mar'18 Mar'19 Mar'20 Mar'21 -651 ROCE = [EBIT/Avg. Capital Employed (Total assets-current liabilities] FCF= CF from operating activities - Capex 9 5-year trajectory: Creating value for stakeholders 5-year CAGR 19% 32,375 25,986 22,792 16,918 14,